13F HOLDINGS REPORT
Finepoint Capital LP
Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0000904454-23-000604
Total Value
$200.8M
Positions
30
Other Managers
0
Confidential Omitted
No
Holdings (30)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 331,416 | $18.9M | 9.41% |
| 2 | AMICUS THERAPEUTICS INC | FOLD | 1,489,025 | $18.1M | 9.02% |
| 3 | SAREPTA THERAPEUTICS INC | SRPT | 145,357 | $17.6M | 8.78% |
| 4 | PROTHENA CORP PLC | PRTA | 349,300 | $16.9M | 8.39% |
| 5 | GALAPAGOS NV | GLPGF | 458,659 | $15.8M | 7.89% |
| 6 | ASCENDIS PHARMA A/S | ASND | 163,772 | $15.3M | 7.64% |
| 7 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 556,928 | $12.9M | 6.41% |
| 8 | CYTOKINETICS INC | CYTK | 431,693 | $12.7M | 6.33% |
| 9 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 563,345 | $12.3M | 6.12% |
| 10 | REVOLUTION MEDICINES INC | RVMDW | 427,000 | $11.8M | 5.89% |
| 11 | ACADIA PHARMACEUTICALS INC | ACAD | 556,553 | $11.6M | 5.78% |
| 12 | ARVINAS INC | ARVN | 504,700 | $9.9M | 4.94% |
| 13 | TRAVERE THERAPEUTICS INC | TVTX | 895,821 | $8.0M | 3.99% |
| 14 | MORPHIC HOLDING INC | 61775R105 | 325,356 | $7.5M | 3.71% |
| 15 | RELAY THERAPEUTICS INC | RLAY | 870,870 | $7.3M | 3.65% |
| 16 | SOLID BIOSCIENCES INC | SLDB | 961,251 | $2.4M | 1.21% |
| 17 | CALIDI BIOTHERAPEUTICS INC | CLDWW | 125,000 | $415,625 | 0.21% |
| 18 | ARES ACQUISITION CORP | G33032122 | 504,706 | $333,611 | 0.17% |
| 19 | BRIDGETOWN HOLDINGS LTD | G1355U121 | 895,000 | $304,300 | 0.15% |
| 20 | CHURCHILL CAPITAL CORP VII | 17144M110 | 548,000 | $168,784 | 0.08% |
| 21 | CALIDI BIOTHERAPEUTICS INC | CLDWW | 655,200 | $144,144 | 0.07% |
| 22 | COMPASS DIGITAL ACQUISITION CORP | COMP | 459,906 | $101,271 | 0.05% |
| 23 | CHURCHILL CAPITAL CORP VI | 17143W119 | 540,000 | $86,400 | 0.04% |
| 24 | ROSS ACQUISITION CORP II | G7641C114 | 439,666 | $49,023 | 0.02% |
| 25 | CONCORD ACQUISITION CORP II | CNDAW | 408,333 | $42,589 | 0.02% |
| 26 | SWIFTMERGE ACQUISITION CORP | G63836111 | 490,000 | $34,594 | 0.02% |
| 27 | YS BIOPHARMA CO LTD | G9845F117 | 489,999 | $17,150 | 0.01% |
| 28 | MARBLEGATE ACQUISITION CORP | 56608A113 | 735,000 | $13,524 | 0.01% |
| 29 | CHURCHILL CAPITAL CORP V | 17144T115 | 612,000 | $0 | 0.00% |
| 30 | HOME PLATE ACQUISITION CORP | 43734R111 | 690,000 | $0 | 0.00% |